Our mission is to make medicines that help people live longer, healthier, more active lives. To achieve this mission, Lilly works with various individuals and organizations to improve patient outcomes and the healthcare system.
We are proud of the support we provide in collaboration with others to help advance the treatment and care of those battling illnesses. We also believe transparency is critical to rebuilding trust in our industry. Lilly was the first company (in 2004) to establish an online database of our clinical trial results, and the first company (in 2007) to establish a public registry of our grants and charitable contributions. And, in 2009, we became the first company to report our payments to physicians for speaking and advising services. Lilly strives to be a leading voice and example in transparency efforts in the biopharmaceutical industry.